Dr Reddy's Laboratories Ltd (RDY)
74.60
+0.58
(+0.78%)
USD |
NYSE |
Apr 26, 15:38
Dr Reddy's Laboratories Accounts Receivable (Quarterly): 939.36M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 939.36M |
September 30, 2023 | 837.92M |
June 30, 2023 | 939.33M |
March 31, 2023 | 882.87M |
December 31, 2022 | 906.78M |
September 30, 2022 | 944.86M |
June 30, 2022 | 927.91M |
March 31, 2022 | 880.48M |
December 31, 2021 | 838.96M |
September 30, 2021 | 923.16M |
June 30, 2021 | 821.42M |
March 31, 2021 | 675.86M |
December 31, 2020 | 723.84M |
September 30, 2020 | 675.89M |
June 30, 2020 | 614.79M |
March 31, 2020 | 666.64M |
December 31, 2019 | 620.49M |
September 30, 2019 | 577.14M |
June 30, 2019 | 545.76M |
March 31, 2019 | 574.07M |
December 31, 2018 | 531.73M |
September 30, 2018 | 636.16M |
June 30, 2018 | 696.38M |
March 31, 2018 | 623.88M |
December 31, 2017 | 664.49M |
Date | Value |
---|---|
September 30, 2017 | 645.71M |
June 30, 2017 | 634.79M |
March 31, 2017 | 586.96M |
December 31, 2016 | 605.27M |
September 30, 2016 | 552.61M |
June 30, 2016 | 526.45M |
March 31, 2016 | 622.07M |
December 31, 2015 | 630.24M |
September 30, 2015 | 649.88M |
June 30, 2015 | 659.45M |
March 31, 2015 | 651.67M |
December 31, 2014 | 634.33M |
September 30, 2014 | 612.61M |
June 30, 2014 | 601.23M |
March 31, 2014 | 552.05M |
December 31, 2013 | 563.26M |
September 30, 2013 | 528.99M |
June 30, 2013 | 484.48M |
March 31, 2013 | 587.65M |
December 31, 2012 | 490.70M |
September 30, 2012 | 495.02M |
June 30, 2012 | 439.56M |
March 31, 2012 | 493.35M |
December 31, 2011 | 497.13M |
September 30, 2011 | 420.62M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
545.76M
Minimum
Jun 2019
944.86M
Maximum
Sep 2022
786.50M
Average
837.92M
Median
Sep 2023
Accounts Receivable (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | 10.37M |
ASLAN Pharmaceuticals Ltd | -- |
Zai Lab Ltd | 59.20M |
Infosys Ltd | 3.620B |
SS Innovations International Inc | -- |